Manufacturer
16 recalls in our database name Sandoz Incorporated as the manufacturing or recalling firm.
Of the 16 recalls from Sandoz Incorporated we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 5 (31%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Sandoz Incorporated is recalling specific lots of Triamterene and Hydrochlorothiazide Tablets due to the presence of unrelated ingredients.
Sandoz Incorporated is recalling specific lots of Amitriptyline Hydrochloride 25 mg tablets because they were cross-contaminated with Imipramine.
Sandoz Incorporated is recalling 96 bottles of Nadolol Tablets, 40mg, because the product failed a required dissolution test.
Sandoz Inc. is recalling one lot of Fluoxetine Capsules because the logo on the capsules is illegible.
Sandoz Incorporated is recalling 1,332 bottles of Alprazolam 0.25mg tablets nationwide because they may contain stainless steel metal particulates.
Sandoz Incorporated is recalling specific lots of Tacrolimus Capsules because trace amounts of fluvastatin were found in the product.
Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets because the logo on some tablets is illegible.
Sandoz Incorporated is recalling specific lots of Methotrexate Injection vials because particulate matter was found in retention samples.
Sandoz is voluntarily recalling Introvale contraceptive tablets because inactive and active pills were placed in the wrong weeks on the blister card.
Sandoz Incorporated is recalling Estarylla tablets because a placebo tablet was found in a row of active tablets, which could reduce contraceptive effectiveness.
Sandoz Inc. is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a lack of assurance of sterility caused by broken or cracked vials.
Sandoz is recalling specific lots of Amoxicillin Capsules USP 500 mg due to potential contamination with fragments of stainless steel wire mesh.
Sandoz is recalling Syeda oral contraceptives because some tablets have the wrong ID imprint. Consumers should stop using the affected lot and contact a healthcare provider.
Sandoz Incorporated is recalling specific lots of Children's Cetirizine Hydrochloride Chewable Tablets because they exceeded impurity specifications.
Sandoz Incorporated is recalling specific lots of Pramipexole Dihydrochloride Tablets because stability testing revealed an out-of-specification impurity.
Sandoz Incorporated is recalling Pramipexole Dihydrochloride Tablets, 0.25 mg, because an out-of-specification result for a known impurity occurred during stability testing.